Voy Weight Management

Voy is a digital weight management programme launched in 2024 as an expansion of Manual, a UK men's health platform founded in 2018. Voy offers injectable weight loss treatment (semaglutide and tirzepatide, marketed under MHRA-compliant descriptions) with clinical coaching and lifestyle support. The platform has quickly grown a substantial user base, leveraging Manual's established infrastructure for online prescribing, pharmacy dispensing, and digital health coaching. Voy is registered with the General Pharmaceutical Council (GPhC) and regulated by the Care Quality Commission (CQC). Monthly pricing is competitive within the full-programme category, typically ranging from £130 to £299 depending on medication type and dose. The programme includes clinician-led consultations, a structured coaching programme, and ongoing dose management support. Voy operates throughout England, Scotland, Wales, and Northern Ireland and ships medication within 24-48 hours of prescription.